Learn / ACRS
NASDAQ: ACRS
Aclaris Therapeutics (ACRS) stock, explained like you're 5
Aclaris Therapeutics trades on the Nasdaq under the ticker ACRS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 564 million dollars.
- Ticker
- ACRS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 564 million dollars
Is Aclaris Therapeutics a small, medium or large cap company?
No. Aclaris Therapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 564 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Aclaris Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ACRS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Aclaris Therapeutics (NasdaqGS:ACRS) Stock Forecast & Analyst Predictions (Simply Wall Street)
- Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength? (Yahoo Finance)
- ACRS Forecast Price Target Prediction for 2027 (TradingView)
- Aclaris Therapeutics, Inc. (ACRS): A Top Penny Stock in Investors Portfolio That Stifel is Bullish On (Yahoo Finance)
- ACRS Oct 2026 8.000 call (ACRS261016C00008000) interactive stock chart (Yahoo Finance UK)
Follow ACRS in your daily brief
Each trading day at 5 PM ET we post what happened to Aclaris Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ACRS
Questions about Aclaris Therapeutics stock
What does Aclaris Therapeutics do?
Aclaris Therapeutics trades on the Nasdaq under the ticker ACRS. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 564 million dollars.
What is the ticker symbol for Aclaris Therapeutics?
Aclaris Therapeutics trades under the ticker ACRS on the Nasdaq.
What is Aclaris Therapeutics's market cap?
Aclaris Therapeutics is a small cap stock with a market cap of about 564 million dollars.
How does Aclaris Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ACRS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ACRS stock every day?
Add ACRS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.